A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural ...

INBRAIN partners with Microsoft to use agentic AI and Azure cloud tech for next-gen brain-computer therapeutics.

The technology works like a translator, not a mind reader – It converts brain scan patterns into coherent sentences by ...

A neural interface framework integrating L2 regularization with attention supervision paradigms achieves 96.87% classification accuracy in EEG ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

Spanish brain-computer interface (BCI) company INBRAIN Neuroelectronics has announced its collaboration with Microsoft to explore AI applications for real-time brain-computer interface therapeutics.

Inbrain will apply Microsoft's agentic AI and cloud tech to its brain-computer interface, which could facilitate faster ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...